碘海醇注射市场按应用、剂型、强度、给药途径、最终用户和地区划分

碘海醇注射市场规模预计在 2025 年为 17.1 亿美元，预计到 2032 年将达到 30.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 8.5%。

全球碘海醇注射市场是药物显影剂产业的重要组成部分，主要贡献于全球医疗保健系统的诊断影像。碘海醇是一种非离子型水溶性显影剂，已成为各种医学影像程序（包括电脑断层扫描 (CT)、血管造影术和造影）的重要组成部分。与离子型显影剂相比，这种低摩尔显影剂具有更高的安全性，在诊断过程中可减少副作用并提高患者耐受性。

市场上涵盖各种规格和包装形式的碘海醇注射液，旨在满足各种诊断成像应用的多样化临床需求。由于其卓越的造影性能、快速的清除机制以及与现代成像技术的兼容性，医疗保健提供者越来越信赖碘海醇注射液。需要诊断影像的慢性疾病的增多，加上新兴国家医疗基础设施的进步，正在推动市场扩张。此外，微创诊断方法的普及以及易患心血管和神经系统疾病的老年人口的不断增长，也对市场成长做出了重要贡献。製药业致力于开发安全性更高、副作用更少的改良剂型，这使得碘海醇注射成为现代诊断医学的重要工具，并进一步推动了这个专业治疗领域的创新。

市场动态

全球碘海醇注射剂市场在一个复杂的生态系统中运作，这个生态系统由市场驱动因素、限制因素和机会组成，这些因素共同决定了市场的发展轨迹。关键的市场驱动因素包括全球日益加重的心血管疾病、癌症和神经系统疾病负担，这些疾病需要先进的诊断影像，增加了对可靠显影剂的需求。新兴市场医疗基础设施的快速扩张，加上医疗成本的上升和政府促进早期疾病检测的倡议，极大地推动了市场的成长。诊断影像设备的技术进步需要相容的显影剂，加上对门诊诊断程序的日益增长的偏好，进一步推动了市场扩张。然而，市场面临重大限制，包括管理显影剂核准流程的严格法律规范、与显影剂相关的潜在副作用以及新製剂的高研发成本。

此外，无需造影显影剂的替代影像技术的可用性以及脆弱患者群体中显影剂剂诱发肾臟病的风险构成了重大挑战。供应链中断和原材料价格波动也会影响市场稳定。然而，透过开发安全性更高的下一代显影剂、扩展到服务不足的地区市场以及製药公司和医疗保健提供者之间的策略联盟，庞大的商机正在涌现。人工智慧在诊断影像领域的日益普及为增强显影剂的使用创造了机会，而新兴国家医疗旅游业的扩张也带来了新的市场潜力。此外，对个人化医疗和精准诊断的日益关注为针对特定患者群体和临床状况量身定制的碘海醇製剂铺平了道路。

本次调查的主要特点

• 本报告对全球碘海醇注射市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，概述了全球碘海醇注射市场的主要企业。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
• 全球碘海醇注射剂市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 透过用于分析全球碘海醇注射剂市场的各种策略矩阵，相关人员将更容易做出决策。

目录

第 1 章：调查目标与先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020 年至 2032 年全球碘海醇注射剂市场（依应用）

• 电脑断层扫描（身体/器官成像）
• 血管造影术/造影
• 造影
• 造影
• 其他（如造影、造影、ERCP）

5. 2020-2032 年全球碘海醇注射市场（按剂型）

• 注射液
• 口服液

6. 2020 年至 2032 年全球碘海醇注射剂市场规模

• 140mgI/mL
• 180mgI/mL
• 240mgI/mL
• 300mgI/mL
• 350mgI/mL
• 9mgI/mL
• 12mgI/mL

7. 2020-2032 年全球碘海醇注射市场（依给药途径）

• 椎管内
• 动脉内
• 静脉
• 口服
• 直肠
• 关节内

8. 2020-2032 年全球碘海醇注射市场（依年龄层划分）

• 成人
• 孩子们

9. 2020-2032 年全球碘海醇注射剂市场（依最终用户划分）

• 医院和专科诊所
• 诊断中心
• 影像中心
• 门诊手术中心
• 其他（研究和学术机构）

第 10 章。 2020-2032 年按地区分列的全球碘海醇注射市场

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章 竞争格局

• GE HealthCare
• Torso Healthcare
• MANUS AKTTEVA BIOPHARMA LLP
• Farbe Firma
• Swasthya Healthcare Pvt. Ltd.
• Intelicure Lifescience
• Onko Ilac Sanayi ve Ticaret AS
• Grupo Juste
• Jiangsu Hengrui Medicine

第 12 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十三章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Iohexol Injection Market is estimated to be valued at USD 1.71 Bn in 2025 and is expected to reach USD 3.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032.

The Global Iohexol Injection Market represents a critical segment within the pharmaceutical contrast media industry, primarily serving diagnostic imaging procedures across healthcare systems worldwide. Iohexol, a non-ionic, water-soluble contrast agent, has established itself as an essential component in various medical imaging modalities including computed tomography (CT), angiography, and urography procedures. This low-osmolar contrast medium demonstrates superior safety profiles compared to ionic alternatives, exhibiting reduced adverse reactions and enhanced patient tolerance during diagnostic examinations.

The market encompasses various concentration formulations and packaging formats designed to meet diverse clinical requirements across different imaging applications. Healthcare providers increasingly rely on Iohexol injections due to their excellent contrast enhancement properties, rapid clearance mechanisms, and compatibility with modern imaging technologies. The growing prevalence of chronic diseases requiring diagnostic imaging, coupled with advancing healthcare infrastructure in emerging economies, continues to drive market expansion. Additionally, the increasing adoption of minimally invasive diagnostic procedures and the rising geriatric population susceptible to cardiovascular and neurological conditions contribute significantly to market growth. The pharmaceutical industry's focus on developing improved formulations with enhanced safety profiles and reduced side effects further propels innovation within this specialized therapeutic segment, positioning Iohexol injections as indispensable tools in contemporary diagnostic medicine.

Market Dynamics

The Global Iohexol Injection Market operates within a complex ecosystem of drivers, restraints, and opportunities that collectively shape its trajectory. Primary market drivers include the escalating global burden of cardiovascular diseases, cancer, and neurological disorders necessitating advanced diagnostic imaging procedures, thereby increasing demand for reliable contrast agents. The rapid expansion of healthcare infrastructure in developing nations, coupled with increasing healthcare expenditure and government initiatives promoting early disease detection, significantly propels market growth. Technological advancements in imaging equipment requiring compatible contrast media, along with the growing preference for outpatient diagnostic procedures, further stimulate market expansion. However, the market faces considerable restraints including stringent regulatory frameworks governing contrast agent approval processes, potential adverse reactions associated with contrast media administration, and the high costs of research and development for new formulations.

Additionally, the availability of alternative imaging techniques that don't require contrast agents and the risk of contrast-induced nephropathy in vulnerable patient populations pose significant challenges. Supply chain disruptions and raw material price volatility also impact market stability. Nevertheless, substantial opportunities emerge through the development of next-generation contrast agents with improved safety profiles, expansion into underserved geographic markets, and strategic partnerships between pharmaceutical companies and healthcare providers. The increasing adoption of artificial intelligence in diagnostic imaging creates opportunities for enhanced contrast agent utilization, while growing medical tourism in emerging economies presents new market avenues. Furthermore, the rising focus on personalized medicine and precision diagnostics opens pathways for specialized Iohexol formulations tailored to specific patient demographics and clinical conditions.

Key Features of the Study

• This report provides in-depth analysis of the global Iohexol injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Iohexol Injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE HealthCare, Torso Healthcare, MANUS AKTTEVA BIOPHARMA LLP, Farbe Firma, Swasthya Healthcare Pvt. Ltd., Intelicure Lifescience, Onko Ilac Sanayi ve Ticaret A.S, Grupo Juste, and Jiangsu Hengrui Medicine
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Iohexol injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Iohexol injection market

Market Segmentation

• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Computed Tomography (CT) Scans (Body/organ imaging)
  • Angiography and Angiocardiography
  • Myelography
  • Arthrography
  • Other Applications (e.g., Urography, Hysterosalpingography, ERCP)
• Dosage Forms Insights (Revenue, USD Bn, 2020 - 2032)
  • Injection
  • Oral Solution
• Strength Insights (Revenue, USD Bn, 2020 - 2032)
  • 140 mg iodine/mL
  • 180 mg iodine/mL
  • 240 mg iodine/mL
  • 300 mg iodine/mL
  • 350 mg iodine/mL
  • 9 mg iodine/mL
  • 12 mg iodine/mL
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Intrathecal
  • Intra-arterial
  • Intravenous
  • Oral
  • Rectal
  • Intraarticular
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adults
  • Pediatric
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Specialty Clinics
  • Diagnostic Centers
  • Imaging Centers
  • Ambulatory Surgical Centers
  • Others (Research and Academic Institutes)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • GE HealthCare
  • Torso Healthcare
  • MANUS AKTTEVA BIOPHARMA LLP
  • Farbe Firma
  • Swasthya Healthcare Pvt. Ltd.
  • Intelicure Lifescience
  • Onko Ilac Sanayi ve Ticaret A.S
  • Grupo Juste
  • Jiangsu Hengrui Medicine

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Iohexol Injection Market, By Application
  • Global Iohexol Injection Market, By Dosage Forms
  • Global Iohexol Injection Market, By Strength
  • Global Iohexol Injection Market, By Route of Administration
  • Global Iohexol Injection Market, By Age Group
  • Global Iohexol Injection Market, By End User
  • Global Iohexol Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Iohexol Injection Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Computed Tomography (CT) Scans (Body/organ imaging)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Angiography and Angiocardiography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Myelography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Arthrography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Applications (e.g., Urography, Hysterosalpingography, ERCP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Iohexol Injection Market, By Dosage Forms, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Iohexol Injection Market, By Strength, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 140 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 180 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 240 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 300 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 350 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 9 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 12 mg iodine/mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Iohexol Injection Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intrathecal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intra-arterial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rectal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intraarticular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Iohexol Injection Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Iohexol Injection Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Imaging Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Research and Academic Institutes)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Iohexol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• GE HealthCare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Torso Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• MANUS AKTTEVA BIOPHARMA LLP
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Farbe Firma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Swasthya Healthcare Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Intelicure Lifescience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Onko Ilac Sanayi ve Ticaret A.S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grupo Juste
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Hengrui Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us